Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00585_DB01066_nanopub.RABHUuUH8UndAJGHuNSDXr2WcV1CTFxiIsF9gmw82DMoI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00585_DB01066 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00585_DB01066 label "DDI between Nizatidine and Cefditoren - H2-Antagonists such as nizatidine may decrease the serum concentration of cefditoren. Cefditoren prescribing information recommends to avoid concomitant use with H2-antagonists (eg, famotidine, ranitidine) and antacids as well. Consider alternative methods to minimize/control acid reflux (eg, diet modification) or alternative antimicrobial therapy if use of H2-antagonists can not be avoided. [drugbank_resource:DB00585_DB01066]" assertion.
- drugbank_resource:DB00585_DB01066 identifier "drugbank_resource:DB00585_DB01066" assertion.
- drugbank_resource:DB00585_DB01066 title "DDI between Nizatidine and Cefditoren - H2-Antagonists such as nizatidine may decrease the serum concentration of cefditoren. Cefditoren prescribing information recommends to avoid concomitant use with H2-antagonists (eg, famotidine, ranitidine) and antacids as well. Consider alternative methods to minimize/control acid reflux (eg, diet modification) or alternative antimicrobial therapy if use of H2-antagonists can not be avoided." assertion.
- drugbank:DB01066 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00585_DB01066 assertion.
- drugbank:DB00585 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00585_DB01066 assertion.